Article thumbnail

Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer

By Vassiliki A. Papadimitrakopoulou, Jean-Charles Soria, Annette Jappe, Valentine Jehl, Judith Klimovsky and Bruce E. Johnson
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Year: 2012
DOI identifier: 10.1097/jto.0b013e3182614835
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles